• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

栀子苷对甲型H1N1流感病毒的抑制作用

张耘实, 祁贤, 卢协勤, 刘星, 冯旰珠

张耘实, 祁贤, 卢协勤, 刘星, 冯旰珠. 栀子苷对甲型H1N1流感病毒的抑制作用[J]. 中国药科大学学报, 2016, 47(2): 204-209. DOI: 10.11665/j.issn.1000-5048.20160213
引用本文: 张耘实, 祁贤, 卢协勤, 刘星, 冯旰珠. 栀子苷对甲型H1N1流感病毒的抑制作用[J]. 中国药科大学学报, 2016, 47(2): 204-209. DOI: 10.11665/j.issn.1000-5048.20160213
shu
ZHANG Yunshi, QI Xian, LU Xieqin, LIU Xing, FENG Ganzhu. Inhibitory effect of geniposide against influenza A/H1N1 virus[J]. Journal of China Pharmaceutical University, 2016, 47(2): 204-209. DOI: 10.11665/j.issn.1000-5048.20160213
Citation: ZHANG Yunshi, QI Xian, LU Xieqin, LIU Xing, FENG Ganzhu. Inhibitory effect of geniposide against influenza A/H1N1 virus[J]. Journal of China Pharmaceutical University, 2016, 47(2): 204-209. DOI: 10.11665/j.issn.1000-5048.20160213
shu

栀子苷对甲型H1N1流感病毒的抑制作用

  • 1.

    南京医科大学第二临床医学院

  • 2.

    江苏省疾病预防控制中心

  • 3.

    南京医科大学第二附属医院药剂科

  • 4.

    南京医科大学第二附属医院呼吸科

基金项目: 国家自然科学基金资助项目(No.81470209)；江苏省中医药管理局项目(No.LZ13228)；南京市卫生局医药科技发展资助项目(No.YKK13176)

Inhibitory effect of geniposide against influenza A/H1N1 virus

摘要

    摘要
  • 摘要: 为探讨栀子苷对甲型H1N1病毒的抑制效应，进行了相关体内外实验研究。体外实验中采用MTT法判定栀子苷对MDCK细胞的毒性作用。以帕拉米韦为阳性对照药，根据MTT比色值，观察栀子苷对甲型H1N1流感病毒感染的MDCK细胞的细胞病变效应(cytopathic effects，CPE)，计算不同给药方式(预防给药、直接灭活及治疗给药)及不同药物剂量干预下，栀子苷对甲型H1N1流感病毒的抑制效率；体内实验以甲型H1N1流感病毒感染ICR小鼠，建立甲型H1N1流感病毒小鼠肺炎模型，比较栀子苷不同剂量干预下，小鼠肺指数、肺组织病理学检查及小鼠存活率。实验结果显示，栀子苷的细胞毒性小，其TD50大于1 040 μmol/L；栀子苷在预防、直接灭活及治疗给药方式下，对甲型H1N1流感病毒感染的MDCK细胞抗病毒EC50分别为91.90、96.25和87.68 μmol/L，对CPE有明显抑制作用；栀子苷可显著降低甲型H1N1流感病毒感染小鼠的肺指数、减轻肺组织炎症损伤、降低小鼠死亡率、延长生存时间。实验结果表明，栀子苷在体外能有效抑制甲型H1N1流感病毒对MDCK细胞的CPE，在体内能有效保护甲型H1N1流感病毒对小鼠肺部的攻击作用，可能为流感病毒的防治提供一个新的选择。
    Abstract: The aim of this study was to explore the protective effects of geniposide against Influenza A(H1N1)pdm09 virus in vitro and in vivo. In vitro, geniposide was administered as a precaution drug, a direct deactivation drug or a treatment drug at different doses. Peramivir was applied as a positive control. The quantitative colorimetric MTT assay was applied to test both the cytotoxicity of geniposide on Madin-Darby Canine Kidney(MDCK)cells and the cytopathogenic effect(CPE)of geniposide on MDCK cells infected by influenza A(H1N1)virus. The viral inhibitory rate of geniposide on NT0901 was also calculated. In vivo, we presented a mouse model of influenza A(H1N1)pdm09 virus infection. Geniposide(5, 10, or 20 mg/kg)or peramivir(30mg/kg)were used as treatment procedures. Lung index and the survival rate were calculated to evaluate the therapeutic effects of geniposide or peramivir on NT0901-infected mice. Haematoxylin and eosin(H&E)stain was used to access the pathological alterations of lung tissues. The study in vitro demonstrated that the TD50(median toxic dose)of geniposide was higher than 1 040 μmol/L. Besides, the EC50(concentration for 50% of maximal effect)of geniposide administered for precaution, direct deactivation and therapy were 91. 90, 96. 25, 87. 68 μmol/L, respectively. These results suggested that geniposide could block the damage of NT0901 on MDCK cells in a dose-dependent manner. The results in vivo showed that geniposide could significantly alleviate the lung index elevation and inflammatory responses in lung tissues induced by NT0901, reduce the mortality of infected mice and extend their survival time. In conclusion, our investigation indicates that geniposide is highly effective in inhibiting cytopathogenic effect and acute lung injury caused by influenza A(H1N1)pdm09 virus. Geniposide may be a potential therapeutic agent for the suppression of influenza virus.
    • HTML全文
    • 参考文献(21)
  • [1] Dawood FS,Jain S,Finelli L,et al.Emergence of a novel swine-origin Influenza A(H1N1)virus in humans[J].N Engl J Med,2009,360(25):2605-2615.
    [2] Henju M,Vasiliy P,Mishin P,et al.An investigational antiviral drug,DAS181,effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality[J].J Infect Dis,2014,210(3):435-440.
    [3] Pizzorno A,Bouhy X,Abed Y,et al.Generation and characterization of recombinant pandemic influenza A(H1N1)viruses resistant to neuraminidase inhibitors[J].J Infect Dis,2011,203(1):25-31.
    [4] Chen JY,Wu H,Li H,et al.Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis[J].Int Immunopharmacol,2015,24(1):102-109.
    [5] Park JH,Yoon J,Lee KY,et al.Effects of geniposide on hepatocytes undergoing epithelial-mesenchymal transition in hepatic fibrosis by targeting TGFβ/Smad and ERK-MAPK signaling pathways[J].Biochimie,2015,113:26-34.
    [6] Chen J,Wu H,Xu GB,et al.Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies[J].J Pharm Biomed Anal,2015,108:122-128.
    [7] Wang J,Zhang Y,Liu R,et al.Geniposide protects against acute alcohol-induced liver injury in mice via up-regulating the expression of the main antioxidant enzymes[J].Can J Physiol Pharmacol,2015,93(4):261-267.
    [8] Song X,Guo M,Wang T,et al.Geniposide inhibited lipopolysaccharide-induced apoptosis by modulating TLR4 and apoptosis-related factors in mouse mammary glands[J].Life Sci,2014,119(1/2):9-17.
    [9] Sung YY,Lee AY,Kim HK.The Gardenia jasminoides extract and its constituent,geniposide,elicit anti-allergic effects on atopic dermatitis by inhibiting histamine in vitro and in vivo[J].J Ethnopharmacol,2014,156:33-40.
    [10] Institute for Viral Disease Control and Prevention,Chinese Center for Disease Control and Prevention.Standard operating procedures for the National Influenza Center:Revised Edition(国家流感中心标准操作规程:修订版)[S].2007,May:45-47.http://www.cnic.org.cn/chn/down/showdown.php?downid=46.
    [11] Zhang CJ,Yu HT.Antagonism of geniposide on Toll-like receptor7/nuclear factor- B signaling pathways in cells with influenza A virus infection[J].Chin J Microbiol Immunol(中华微生物和免疫学杂志),2009,30(8):749-754.
    [12] Li JH,Lin FF,Du JY,et al.Antiviral effects of baicalin combined with peramivir against pandemic 2009 H1N1 virus in vitro and in vivo[J].Chin Pharmacol Bull(中国药理学通报),2013,29(5):617-621.
    [13] You WL,Ping QN,Sun MJ,et al.Recent progress in pharmacology of geniposide[J].Prog Pharm Sci(药学进展),2012,36(4):158-162.
    [14] Zhang Y,Xia Z,Liu J,et al.Cell signaling mechanisms by which geniposide regulates insulin-degrading enzyme expression in primary cortical neurons[J].CNS Neurol Disord Drug Targets,2015,14(3):370-377.
    [15] Lv C,Wang L,Liu X,et al.Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model[J].Neuropharmacology,2015,89:175-184.
    [16] Zhang Y,Yin F,Liu J,et al.Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer′s disease[J].Neurochem Int,2015,89:7-16.
    [17] Liu W,Li G,Hölscher C,et al.Neuroprotective effects of geniposide on Alzheimer′s disease pathology[J].Rev Neurosci,2015,26(4):371-383.
    [18] Liao P,Liu L,Wang B,et al.Baicalin and geniposide attenuate atherosclerosis involving lipids regulation and immunoregulation in ApoE-/- mice[J].Eur J Pharmacol,2014,740:488-495.
    [19] Guo SS,Huang Y,Zhao Y,et al.Effect of extracted ZG from gardenia on Hep-2 cell membrane post infected with parainfluenza virus type 1(PIV-1)[J].Chin J Virol(病毒学报),2007,23(5):384-388.
    [20] Han JW,Li J,Huang C,et al.Transport of geniposide and geniposide in Zhizi Bopi Decoction in MDCK cell membrane model[J].Chin Pharmacol Bull(中国药理学通报),2014,30(4):468-472.
    [21] Guadalupe MG, Ramcés FV, Román AGR, et al. Pandemic influenza A/H1N1 virus infection and TNF,LTA,IL1B,IL6,IL8,and CCL polymorphisms in Mexican population:a case-control study[J].BMC Infect Dis,2012,12:299.
    • 相关文章
    • 施引文献(3)

  • 期刊类型引用(2)

    1. 方建伟，沈永玲，程飞，桑晓一，孟君，马翠红，戈洪国. 血清IGF-1、Tau蛋白对老年轻型缺血性脑卒中患者脑卒中后认知障碍的预测价值. 中国老年学杂志. 2024(13): 3158-3161 . 百度学术
    2. 蒋泽文，钟金，刘贤文，李晶，龚享文. 血清25(OH)D、SAA、Hcy水平对慢性阻塞性肺疾病患者认知障碍的诊断价值. 检验医学与临床. 2022(18): 2463-2466+2472 . 百度学术

    其他类型引用(1)

    • 资源附件(0)
计量
  • 文章访问数: 
  • HTML全文浏览量:  0
  • PDF下载量: 
  • 被引次数: 3
出版历程
  • 刊出日期:  2016-04-24

目录

摘要
HTML全文
    参考文献(21)
    相关文章
    施引文献(3)
    资源附件(0)

    /

    返回文章
    返回

    版权所有：《中国药科大学学报》编辑部苏ICP备05007142号

    地址：江苏省南京市鼓楼区童家巷24号（210009）电话: 025-83271566E-mail: xuebao@cpu.edu.cn

    本系统由 北京仁和汇智信息技术有限公司 开发  百度统计

    访问量：315845

    x 关闭 永久关闭